• Profile
Close

The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage

European Journal of Obstetrics & Gynecology and Reproductive Biology Jul 30, 2018

Siew JYS, et al. - Researchers performed a comparison of clinical outcomes of miscarriage, extent of vaginal bleeding at follow-up and side effects between women presenting with threatened miscarriage receiving micronised progesterone (MP) vs dydrogesterone (DYD). Findings suggest MP vs DYD had comparable results regarding the extent of bleeding at day 4-10 and subsequent miscarriage rates. However, drowsiness and giddiness were reported by fewer patients treated with DYD. They emphasize considering significantly higher miscarriage rates in women with low progesterone levels despite treatment, in counseling and prognosticating pregnancy outcomes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay